Neumora Therapeutics, Inc. (NMRA)
2.64
-0.19
(-6.71%)
USD |
NASDAQ |
Mar 18, 16:00
2.635
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Shareholders Equity (Quarterly) : 132.16M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 26.54B |
| Protalix Biotherapeutics, Inc. | 48.23M |
| Nautilus Biotechnology, Inc. | 156.97M |
| Ventyx Biosciences, Inc. (DELISTED) | 191.36M |
| ProKidney Corp. | -1.008B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 177.83M |
| Total Liabilities (Quarterly) | 45.67M |
| Debt to Equity Ratio | 0.152 |
| Current Ratio | 6.852 |
| Net Debt Paydown Yield | -1.12% |